July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications.
Thought Leader Select, headquartered in Chapel Hill, North Carolina, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies, as they reach out to and collaborate with leading medical experts to advance treatment options and promote better health worldwide.
For the engagement, Thought Leader Select’s in-house research team will identify and profile dozens of leading Canadian medical experts in pathology, with a focus on KOLs who have experience in developing companion diagnostics for cancer treatments. The company will also assess the top Canadian medical centers of excellence in pathology, delivering engagement plans that will drive interactions among the biopharma client company and its partners in medicine.
The client company, as it develops companion diagnostics for cancer medications, seeks understanding of the provincial reimbursement process and market access climate for such products, as well as learning the degrees to which medical centers of excellence optimize cancer treatment through the use of companion diagnostics.
Thought Leader Select’s work will combine the company’s objective, validated assessment methodology applied to the skills and experience of key opinion leaders in medicine with a series of KOL interviews that glean preliminary insights on the Canadian companion diagnostics market.
“We appreciate the trust that the client has shown in us at Thought Leader Select,” stated Neil Mellor, the company’s global business consultant based in Toronto. “This is such an important space, where we match the leading physicians in companion diagnostics with companies that are meeting critical needs for patients suffering from deadly, debilitating cancers. This is a great opportunity for us to have a huge impact on the collaborative process between the company and key opinion leaders, as we are identifying and profiling KOLs and centers, executing qualitative studies to glean KOL insights on the space, and complementing all of this work with engagement strategies that will ultimately benefit patients across Canada.”
About Thought Leader Select
Thought Leader Select is a Chapel Hill, NC-based private consulting firm serving the biopharmaceutical, medical device, and diagnostics industries with strategies, in-house research, and a suite of engagement tools and support for collaborating with and reaching out to key opinion leaders and centers of excellence in medicine.
Thought Leader Select has supported companies as they develop effective treatments to promote better patient and public health across more than 18 therapeutic areas and 50 diseases and conditions. Thought Leader Select’s customized work strengthens medical marketing initiatives, medical affairs outreach, and payer marketing strategies to support market access, pricing, and reimbursement issues.
Media Contact:
Brian Castle, Director of Global Marketing and Client Relations
Phone: 919-360-9690
E-mail: bcastle@thoughtleaderselect.com
